Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma 1Neuroblastoma 1Lymphoma 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Radiotherapy 5Melphalan 4Filgrastim 4Busulfan 4Topotecan 3Methylprednisolone 3Cyclophosphamide 3Carboplatin 3Vorinostat 2Voriconazole 2Thiotepa 2Therapeutics 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Itraconazole 2Flow Cytometry 2Early Intervention, Educational 2Antilymphocyte Serum 2Amplified Fragment Length Polymorphism Analysis 2trioctyl phosphine oxide 1sargramostim 1liposomal amphotericin B 1ispinesib 1imetelstat 1gallium nitrate 1fludarabine phosphate 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × gallium nitrate × CNS × Clear all
NCT00002543 2013-07-18

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
CNSLymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡